1. Home
  2. ADMA vs TIGO Comparison

ADMA vs TIGO Comparison

Compare ADMA & TIGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADMA
  • TIGO
  • Stock Information
  • Founded
  • ADMA 2004
  • TIGO 1990
  • Country
  • ADMA United States
  • TIGO Luxembourg
  • Employees
  • ADMA N/A
  • TIGO N/A
  • Industry
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • TIGO Telecommunications Equipment
  • Sector
  • ADMA Health Care
  • TIGO Telecommunications
  • Exchange
  • ADMA Nasdaq
  • TIGO Nasdaq
  • Market Cap
  • ADMA 5.1B
  • TIGO 6.0B
  • IPO Year
  • ADMA N/A
  • TIGO 1994
  • Fundamental
  • Price
  • ADMA $18.51
  • TIGO $38.02
  • Analyst Decision
  • ADMA Strong Buy
  • TIGO Buy
  • Analyst Count
  • ADMA 3
  • TIGO 5
  • Target Price
  • ADMA $27.67
  • TIGO $38.90
  • AVG Volume (30 Days)
  • ADMA 3.3M
  • TIGO 1.2M
  • Earning Date
  • ADMA 08-07-2025
  • TIGO 08-07-2025
  • Dividend Yield
  • ADMA N/A
  • TIGO 7.91%
  • EPS Growth
  • ADMA N/A
  • TIGO 5635.24
  • EPS
  • ADMA 0.84
  • TIGO 2.06
  • Revenue
  • ADMA $459,381,000.00
  • TIGO $5,691,000,000.00
  • Revenue This Year
  • ADMA $23.35
  • TIGO N/A
  • Revenue Next Year
  • ADMA $27.67
  • TIGO $2.39
  • P/E Ratio
  • ADMA $22.16
  • TIGO $17.99
  • Revenue Growth
  • ADMA 62.23
  • TIGO N/A
  • 52 Week Low
  • ADMA $10.21
  • TIGO $23.61
  • 52 Week High
  • ADMA $25.67
  • TIGO $38.92
  • Technical
  • Relative Strength Index (RSI)
  • ADMA 46.05
  • TIGO 58.64
  • Support Level
  • ADMA $17.90
  • TIGO $36.59
  • Resistance Level
  • ADMA $18.69
  • TIGO $38.92
  • Average True Range (ATR)
  • ADMA 0.62
  • TIGO 0.92
  • MACD
  • ADMA 0.10
  • TIGO -0.01
  • Stochastic Oscillator
  • ADMA 74.12
  • TIGO 70.63

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

About TIGO Millicom International Cellular S.A.

Millicom offers wireless and fixed-line telecom services primarily in smaller, less developed countries in Latin America. Countries served include Bolivia (100% owned), Nicaragua (100%), Panama (100%), El Salvador (100%), Guatemala (100%), Paraguay (100%), Colombia (50%), and Honduras (67% but not controlled or consolidated in the firm's financial statements). The firm's wireless networks cover about 120 million people, serving 42 million customers. Its fixed-line networks reach 14 million homes, serving about 4 million broadband customers. Increasingly, Millicom offers converged packages that include broadband with wireless services. The firm has agreed to sell the majority of its wireless towers to SBA Communications for $975 million.

Share on Social Networks: